nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—DRD4—obesity	0.0575	0.152	CbGaD
Asenapine—HTR1B—obesity	0.051	0.135	CbGaD
Asenapine—DRD1—obesity	0.0486	0.129	CbGaD
Asenapine—ADRB1—obesity	0.0452	0.12	CbGaD
Asenapine—HTR2C—obesity	0.0416	0.11	CbGaD
Asenapine—ADRB2—obesity	0.038	0.101	CbGaD
Asenapine—HRH2—Cimetidine—obesity	0.0368	0.0925	CbGbCtD
Asenapine—SLC6A4—obesity	0.0345	0.0914	CbGaD
Asenapine—DRD2—obesity	0.0343	0.0909	CbGaD
Asenapine—SLC6A4—Sibutramine—obesity	0.0318	0.08	CbGbCtD
Asenapine—HTR2A—obesity	0.0265	0.0703	CbGaD
Asenapine—DRD1—Phenylpropanolamine—obesity	0.0263	0.0661	CbGbCtD
Asenapine—SLC6A4—Phentermine—obesity	0.0241	0.0606	CbGbCtD
Asenapine—ADRB2—Phenylpropanolamine—obesity	0.023	0.0578	CbGbCtD
Asenapine—ADRA1A—Phendimetrazine—obesity	0.023	0.0578	CbGbCtD
Asenapine—ADRB1—Phenylpropanolamine—obesity	0.0227	0.0569	CbGbCtD
Asenapine—ADRA2C—Methamphetamine—obesity	0.022	0.0554	CbGbCtD
Asenapine—ADRA2B—Methamphetamine—obesity	0.0209	0.0525	CbGbCtD
Asenapine—SLC6A4—Methamphetamine—obesity	0.0193	0.0485	CbGbCtD
Asenapine—ADRA2A—Benzphetamine—obesity	0.0182	0.0457	CbGbCtD
Asenapine—ADRA1A—Benzphetamine—obesity	0.0174	0.0438	CbGbCtD
Asenapine—ADRA2A—Phenylpropanolamine—obesity	0.0173	0.0436	CbGbCtD
Asenapine—ADRA1A—Phenylpropanolamine—obesity	0.0166	0.0418	CbGbCtD
Asenapine—ADRA2A—Methamphetamine—obesity	0.0145	0.0365	CbGbCtD
Asenapine—CYP1A2—Phentermine—obesity	0.00734	0.0184	CbGbCtD
Asenapine—CYP1A2—Phenylpropanolamine—obesity	0.007	0.0176	CbGbCtD
Asenapine—CYP1A2—Bupropion—obesity	0.00624	0.0157	CbGbCtD
Asenapine—CYP2D6—Phentermine—obesity	0.00605	0.0152	CbGbCtD
Asenapine—CYP2D6—Bupropion—obesity	0.00514	0.0129	CbGbCtD
Asenapine—CYP3A4—Sibutramine—obesity	0.00507	0.0128	CbGbCtD
Asenapine—CYP2D6—Methamphetamine—obesity	0.00483	0.0122	CbGbCtD
Asenapine—CYP1A2—Cimetidine—obesity	0.00458	0.0115	CbGbCtD
Asenapine—CYP3A4—Benzphetamine—obesity	0.00384	0.00967	CbGbCtD
Asenapine—CYP2D6—Cimetidine—obesity	0.00377	0.00949	CbGbCtD
Asenapine—CYP3A4—Bupropion—obesity	0.00327	0.00822	CbGbCtD
Asenapine—CYP3A4—Orlistat—obesity	0.00266	0.0067	CbGbCtD
Asenapine—CYP3A4—Cimetidine—obesity	0.0024	0.00603	CbGbCtD
Asenapine—HTR7—sympathetic nervous system—obesity	0.0017	0.0664	CbGeAlD
Asenapine—HTR7—vagus nerve—obesity	0.00164	0.0643	CbGeAlD
Asenapine—CYP3A4—Topiramate—obesity	0.00157	0.00395	CbGbCtD
Asenapine—HTR7—autonomic nervous system—obesity	0.00114	0.0446	CbGeAlD
Asenapine—HTR2A—sympathetic nervous system—obesity	0.00106	0.0414	CbGeAlD
Asenapine—HTR2A—vagus nerve—obesity	0.00103	0.0401	CbGeAlD
Asenapine—UGT1A4—respiratory system—obesity	0.000921	0.036	CbGeAlD
Asenapine—HTR2A—autonomic nervous system—obesity	0.000712	0.0278	CbGeAlD
Asenapine—UGT1A4—digestive system—obesity	0.000586	0.0229	CbGeAlD
Asenapine—SLC6A4—hindbrain—obesity	0.000567	0.0222	CbGeAlD
Asenapine—HTR1A—hindbrain—obesity	0.000503	0.0197	CbGeAlD
Asenapine—UGT1A4—endocrine gland—obesity	0.000484	0.0189	CbGeAlD
Asenapine—HTR7—hindbrain—obesity	0.000481	0.0188	CbGeAlD
Asenapine—ADRA1A—hindbrain—obesity	0.000464	0.0181	CbGeAlD
Asenapine—DRD2—hindbrain—obesity	0.000455	0.0178	CbGeAlD
Asenapine—HRH2—cardiovascular system—obesity	0.000442	0.0173	CbGeAlD
Asenapine—UGT1A4—liver—obesity	0.000436	0.0171	CbGeAlD
Asenapine—HRH2—digestive system—obesity	0.000367	0.0144	CbGeAlD
Asenapine—HRH2—adrenal gland—obesity	0.00035	0.0137	CbGeAlD
Asenapine—SLC6A4—respiratory system—obesity	0.000346	0.0135	CbGeAlD
Asenapine—HRH2—endocrine gland—obesity	0.000303	0.0119	CbGeAlD
Asenapine—HTR2A—hindbrain—obesity	0.0003	0.0117	CbGeAlD
Asenapine—HTR7—respiratory system—obesity	0.000294	0.0115	CbGeAlD
Asenapine—HTR1B—cardiovascular system—obesity	0.000292	0.0114	CbGeAlD
Asenapine—HTR2B—adrenal cortex—obesity	0.000288	0.0113	CbGeAlD
Asenapine—HTR1D—cardiovascular system—obesity	0.000282	0.011	CbGeAlD
Asenapine—DRD2—respiratory system—obesity	0.000278	0.0109	CbGeAlD
Asenapine—ADRB1—cardiovascular system—obesity	0.000274	0.0107	CbGeAlD
Asenapine—HRH2—liver—obesity	0.000274	0.0107	CbGeAlD
Asenapine—CYP2D6—hindbrain—obesity	0.000273	0.0107	CbGeAlD
Asenapine—HTR2B—cardiovascular system—obesity	0.000263	0.0103	CbGeAlD
Asenapine—ADRB1—adipose tissue—obesity	0.000242	0.00946	CbGeAlD
Asenapine—HTR1A—cardiovascular system—obesity	0.000235	0.0092	CbGeAlD
Asenapine—CYP1A2—respiratory system—obesity	0.000234	0.00916	CbGeAlD
Asenapine—HTR2B—adipose tissue—obesity	0.000232	0.00905	CbGeAlD
Asenapine—Amoxapine—DRD4—obesity	0.000228	0.103	CrCbGaD
Asenapine—ADRA2A—islet of Langerhans—obesity	0.000228	0.00892	CbGeAlD
Asenapine—ADRA2C—adrenal cortex—obesity	0.000227	0.00886	CbGeAlD
Asenapine—HTR7—cardiovascular system—obesity	0.000225	0.00879	CbGeAlD
Asenapine—Headache—Benzphetamine—obesity	0.000222	0.00246	CcSEcCtD
Asenapine—Breast disorder—Orlistat—obesity	0.000222	0.00246	CcSEcCtD
Asenapine—Increased appetite—Bupropion—obesity	0.00022	0.00244	CcSEcCtD
Asenapine—SLC6A4—digestive system—obesity	0.00022	0.0086	CbGeAlD
Asenapine—HRH1—respiratory system—obesity	0.000219	0.00857	CbGeAlD
Asenapine—Anaphylactic shock—Cimetidine—obesity	0.000218	0.00242	CcSEcCtD
Asenapine—HTR2B—digestive system—obesity	0.000218	0.00852	CbGeAlD
Asenapine—ADRA1A—cardiovascular system—obesity	0.000217	0.00848	CbGeAlD
Asenapine—Orthostatic hypotension—Sibutramine—obesity	0.000217	0.0024	CcSEcCtD
Asenapine—Thrombocytopenia—Cimetidine—obesity	0.000214	0.00237	CcSEcCtD
Asenapine—Dizziness—Phendimetrazine—obesity	0.000213	0.00237	CcSEcCtD
Asenapine—Tachycardia—Cimetidine—obesity	0.000213	0.00236	CcSEcCtD
Asenapine—Nausea—Benzphetamine—obesity	0.00021	0.00233	CcSEcCtD
Asenapine—Alanine aminotransferase increased—Sibutramine—obesity	0.000209	0.00232	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Diethylpropion—obesity	0.000209	0.00232	CcSEcCtD
Asenapine—HTR2B—adrenal gland—obesity	0.000208	0.00812	CbGeAlD
Asenapine—Insomnia—Diethylpropion—obesity	0.000208	0.0023	CcSEcCtD
Asenapine—Pain in extremity—Bupropion—obesity	0.000207	0.00229	CcSEcCtD
Asenapine—Osteoarthritis—Bupropion—obesity	0.000207	0.00229	CcSEcCtD
Asenapine—Amenorrhoea—Topiramate—obesity	0.000207	0.00229	CcSEcCtD
Asenapine—Dysphagia—Sibutramine—obesity	0.000205	0.00227	CcSEcCtD
Asenapine—Dyspnoea—Diethylpropion—obesity	0.000205	0.00227	CcSEcCtD
Asenapine—Somnolence—Diethylpropion—obesity	0.000204	0.00226	CcSEcCtD
Asenapine—Abdominal discomfort—Orlistat—obesity	0.000203	0.00225	CcSEcCtD
Asenapine—Hypersensitivity—Phenylpropanolamine—obesity	0.000203	0.00225	CcSEcCtD
Asenapine—Amoxapine—HTR1B—obesity	0.000203	0.0913	CrCbGaD
Asenapine—Headache—Phendimetrazine—obesity	0.000202	0.00224	CcSEcCtD
Asenapine—Psychotic disorder—Bupropion—obesity	0.000202	0.00224	CcSEcCtD
Asenapine—Dyspepsia—Diethylpropion—obesity	0.000202	0.00224	CcSEcCtD
Asenapine—HTR1B—endocrine gland—obesity	0.0002	0.00782	CbGeAlD
Asenapine—Musculoskeletal discomfort—Cimetidine—obesity	0.000199	0.00221	CcSEcCtD
Asenapine—Gastrointestinal disorder—Diethylpropion—obesity	0.000198	0.0022	CcSEcCtD
Asenapine—Irritability—Bupropion—obesity	0.000198	0.00219	CcSEcCtD
Asenapine—Constipation—Diethylpropion—obesity	0.000196	0.00218	CcSEcCtD
Asenapine—Somnolence—Cimetidine—obesity	0.000194	0.00215	CcSEcCtD
Asenapine—Dyskinesia—Topiramate—obesity	0.000193	0.00214	CcSEcCtD
Asenapine—Amoxapine—DRD1—obesity	0.000193	0.087	CrCbGaD
Asenapine—Dysarthria—Topiramate—obesity	0.000192	0.00213	CcSEcCtD
Asenapine—Nausea—Phendimetrazine—obesity	0.000192	0.00213	CcSEcCtD
Asenapine—ADRA1A—adipose tissue—obesity	0.000191	0.00748	CbGeAlD
Asenapine—Asthenia—Phentermine—obesity	0.000189	0.0021	CcSEcCtD
Asenapine—Orthostatic hypotension—Bupropion—obesity	0.000189	0.0021	CcSEcCtD
Asenapine—Depression—Orlistat—obesity	0.000189	0.00209	CcSEcCtD
Asenapine—Fatigue—Cimetidine—obesity	0.000188	0.00209	CcSEcCtD
Asenapine—DRD2—pituitary gland—obesity	0.000188	0.00736	CbGeAlD
Asenapine—ADRB1—endocrine gland—obesity	0.000188	0.00736	CbGeAlD
Asenapine—Breast disorder—Bupropion—obesity	0.000187	0.00207	CcSEcCtD
Asenapine—Constipation—Cimetidine—obesity	0.000187	0.00207	CcSEcCtD
Asenapine—Weight increased—Sibutramine—obesity	0.000187	0.00207	CcSEcCtD
Asenapine—HTR7—digestive system—obesity	0.000187	0.0073	CbGeAlD
Asenapine—HTR1A—adrenal gland—obesity	0.000186	0.00728	CbGeAlD
Asenapine—Hyperglycaemia—Sibutramine—obesity	0.000185	0.00205	CcSEcCtD
Asenapine—HTR2A—respiratory system—obesity	0.000183	0.00716	CbGeAlD
Asenapine—ADRA2C—pituitary gland—obesity	0.000183	0.00716	CbGeAlD
Asenapine—Depression—Sibutramine—obesity	0.000182	0.00202	CcSEcCtD
Asenapine—Dizziness—Phenylpropanolamine—obesity	0.000182	0.00202	CcSEcCtD
Asenapine—ADRA2C—adipose tissue—obesity	0.000182	0.00713	CbGeAlD
Asenapine—SLC6A4—endocrine gland—obesity	0.000182	0.00711	CbGeAlD
Asenapine—Pulmonary embolism—Topiramate—obesity	0.000182	0.00201	CcSEcCtD
Asenapine—Dysphagia—Bupropion—obesity	0.000179	0.00198	CcSEcCtD
Asenapine—Hepatobiliary disease—Orlistat—obesity	0.000179	0.00198	CcSEcCtD
Asenapine—Stomatitis—Sibutramine—obesity	0.000178	0.00198	CcSEcCtD
Asenapine—Loxapine—DRD4—obesity	0.000178	0.0803	CrCbGaD
Asenapine—HTR7—adrenal gland—obesity	0.000178	0.00696	CbGeAlD
Asenapine—Salivary hypersecretion—Topiramate—obesity	0.000176	0.00196	CcSEcCtD
Asenapine—Vomiting—Phenylpropanolamine—obesity	0.000175	0.00194	CcSEcCtD
Asenapine—Dizziness—Phentermine—obesity	0.000174	0.00193	CcSEcCtD
Asenapine—Rash—Phenylpropanolamine—obesity	0.000174	0.00193	CcSEcCtD
Asenapine—Dermatitis—Phenylpropanolamine—obesity	0.000174	0.00193	CcSEcCtD
Asenapine—ADRA1A—adrenal gland—obesity	0.000172	0.00671	CbGeAlD
Asenapine—Abdominal discomfort—Bupropion—obesity	0.000172	0.0019	CcSEcCtD
Asenapine—Vomiting—Phentermine—obesity	0.000168	0.00186	CcSEcCtD
Asenapine—Oedema peripheral—Orlistat—obesity	0.000167	0.00185	CcSEcCtD
Asenapine—Rash—Phentermine—obesity	0.000166	0.00184	CcSEcCtD
Asenapine—Dermatitis—Phentermine—obesity	0.000166	0.00184	CcSEcCtD
Asenapine—Amoxapine—HTR2C—obesity	0.000165	0.0744	CrCbGaD
Asenapine—Headache—Phentermine—obesity	0.000165	0.00183	CcSEcCtD
Asenapine—Mouth ulceration—Topiramate—obesity	0.000164	0.00182	CcSEcCtD
Asenapine—Nausea—Phenylpropanolamine—obesity	0.000164	0.00182	CcSEcCtD
Asenapine—ADRA2C—adrenal gland—obesity	0.000164	0.00639	CbGeAlD
Asenapine—Weight increased—Bupropion—obesity	0.000163	0.0018	CcSEcCtD
Asenapine—Oedema peripheral—Sibutramine—obesity	0.000162	0.00179	CcSEcCtD
Asenapine—HTR1A—endocrine gland—obesity	0.000161	0.00631	CbGeAlD
Asenapine—Hyperglycaemia—Bupropion—obesity	0.000161	0.00179	CcSEcCtD
Asenapine—Hypersensitivity—Cimetidine—obesity	0.000161	0.00178	CcSEcCtD
Asenapine—Loxapine—HTR1B—obesity	0.000158	0.0713	CrCbGaD
Asenapine—Nausea—Phentermine—obesity	0.000157	0.00174	CcSEcCtD
Asenapine—Asthenia—Cimetidine—obesity	0.000157	0.00174	CcSEcCtD
Asenapine—Stomatitis—Bupropion—obesity	0.000155	0.00172	CcSEcCtD
Asenapine—HTR7—endocrine gland—obesity	0.000154	0.00603	CbGeAlD
Asenapine—Eye disorder—Sibutramine—obesity	0.000153	0.0017	CcSEcCtD
Asenapine—Immune system disorder—Orlistat—obesity	0.000153	0.0017	CcSEcCtD
Asenapine—Mediastinal disorder—Orlistat—obesity	0.000153	0.0017	CcSEcCtD
Asenapine—Dizziness—Diethylpropion—obesity	0.000152	0.00168	CcSEcCtD
Asenapine—Diabetes mellitus—Topiramate—obesity	0.000152	0.00168	CcSEcCtD
Asenapine—Loxapine—DRD1—obesity	0.000151	0.068	CrCbGaD
Asenapine—Angiopathy—Sibutramine—obesity	0.000149	0.00165	CcSEcCtD
Asenapine—CYP1A2—digestive system—obesity	0.000149	0.00582	CbGeAlD
Asenapine—ADRA1A—endocrine gland—obesity	0.000149	0.00582	CbGeAlD
Asenapine—Mental disorder—Orlistat—obesity	0.000149	0.00165	CcSEcCtD
Asenapine—Immune system disorder—Sibutramine—obesity	0.000148	0.00164	CcSEcCtD
Asenapine—HRH1—adipose tissue—obesity	0.000148	0.00579	CbGeAlD
Asenapine—Malnutrition—Orlistat—obesity	0.000148	0.00164	CcSEcCtD
Asenapine—ADRA2A—pituitary gland—obesity	0.000146	0.00571	CbGeAlD
Asenapine—Vomiting—Diethylpropion—obesity	0.000146	0.00162	CcSEcCtD
Asenapine—DRD2—endocrine gland—obesity	0.000146	0.0057	CbGeAlD
Asenapine—ADRA2A—adipose tissue—obesity	0.000145	0.00569	CbGeAlD
Asenapine—Rash—Diethylpropion—obesity	0.000145	0.0016	CcSEcCtD
Asenapine—Dysgeusia—Orlistat—obesity	0.000145	0.0016	CcSEcCtD
Asenapine—Dermatitis—Diethylpropion—obesity	0.000145	0.0016	CcSEcCtD
Asenapine—Dizziness—Cimetidine—obesity	0.000144	0.0016	CcSEcCtD
Asenapine—Headache—Diethylpropion—obesity	0.000144	0.00159	CcSEcCtD
Asenapine—Malnutrition—Sibutramine—obesity	0.000143	0.00158	CcSEcCtD
Asenapine—Muscle spasms—Orlistat—obesity	0.000142	0.00157	CcSEcCtD
Asenapine—Oedema peripheral—Bupropion—obesity	0.000141	0.00156	CcSEcCtD
Asenapine—Connective tissue disorder—Bupropion—obesity	0.000141	0.00156	CcSEcCtD
Asenapine—Increased appetite—Topiramate—obesity	0.00014	0.00156	CcSEcCtD
Asenapine—HTR2A—cardiovascular system—obesity	0.00014	0.00548	CbGeAlD
Asenapine—Loxapine—ADRB1—obesity	0.00014	0.0631	CrCbGaD
Asenapine—Dysgeusia—Sibutramine—obesity	0.00014	0.00155	CcSEcCtD
Asenapine—HRH1—digestive system—obesity	0.000139	0.00545	CbGeAlD
Asenapine—HTR7—liver—obesity	0.000139	0.00544	CbGeAlD
Asenapine—Vomiting—Cimetidine—obesity	0.000139	0.00154	CcSEcCtD
Asenapine—Rash—Cimetidine—obesity	0.000138	0.00153	CcSEcCtD
Asenapine—Dermatitis—Cimetidine—obesity	0.000138	0.00152	CcSEcCtD
Asenapine—Muscle spasms—Sibutramine—obesity	0.000137	0.00152	CcSEcCtD
Asenapine—Amoxapine—SLC6A4—obesity	0.000137	0.0617	CrCbGaD
Asenapine—Headache—Cimetidine—obesity	0.000137	0.00152	CcSEcCtD
Asenapine—Nausea—Diethylpropion—obesity	0.000136	0.00151	CcSEcCtD
Asenapine—Amoxapine—DRD2—obesity	0.000136	0.0614	CrCbGaD
Asenapine—Angioedema—Orlistat—obesity	0.000135	0.0015	CcSEcCtD
Asenapine—ADRA1A—liver—obesity	0.000134	0.00525	CbGeAlD
Asenapine—Tremor—Sibutramine—obesity	0.000134	0.00148	CcSEcCtD
Asenapine—Eye disorder—Bupropion—obesity	0.000134	0.00148	CcSEcCtD
Asenapine—Malaise—Orlistat—obesity	0.000133	0.00148	CcSEcCtD
Asenapine—Cardiac disorder—Bupropion—obesity	0.000133	0.00147	CcSEcCtD
Asenapine—HRH1—adrenal gland—obesity	0.000133	0.00519	CbGeAlD
Asenapine—Hyponatraemia—Topiramate—obesity	0.000132	0.00147	CcSEcCtD
Asenapine—Anaemia—Sibutramine—obesity	0.000132	0.00146	CcSEcCtD
Asenapine—Osteoarthritis—Topiramate—obesity	0.000132	0.00146	CcSEcCtD
Asenapine—Pain in extremity—Topiramate—obesity	0.000132	0.00146	CcSEcCtD
Asenapine—Agitation—Sibutramine—obesity	0.000131	0.00146	CcSEcCtD
Asenapine—Angioedema—Sibutramine—obesity	0.000131	0.00145	CcSEcCtD
Asenapine—ADRA2A—adrenal gland—obesity	0.00013	0.0051	CbGeAlD
Asenapine—Angiopathy—Bupropion—obesity	0.00013	0.00144	CcSEcCtD
Asenapine—Nausea—Cimetidine—obesity	0.00013	0.00144	CcSEcCtD
Asenapine—Immune system disorder—Bupropion—obesity	0.000129	0.00143	CcSEcCtD
Asenapine—Loxapine—HTR2C—obesity	0.000129	0.0581	CrCbGaD
Asenapine—Mediastinal disorder—Bupropion—obesity	0.000129	0.00143	CcSEcCtD
Asenapine—Malaise—Sibutramine—obesity	0.000129	0.00143	CcSEcCtD
Asenapine—Psychotic disorder—Topiramate—obesity	0.000129	0.00143	CcSEcCtD
Asenapine—Syncope—Sibutramine—obesity	0.000128	0.00142	CcSEcCtD
Asenapine—Convulsion—Orlistat—obesity	0.000128	0.00142	CcSEcCtD
Asenapine—Leukopenia—Sibutramine—obesity	0.000128	0.00142	CcSEcCtD
Asenapine—ADRA2C—liver—obesity	0.000128	0.005	CbGeAlD
Asenapine—Irritability—Topiramate—obesity	0.000126	0.0014	CcSEcCtD
Asenapine—Loss of consciousness—Sibutramine—obesity	0.000126	0.00139	CcSEcCtD
Asenapine—Mental disorder—Bupropion—obesity	0.000125	0.00139	CcSEcCtD
Asenapine—Anxiety—Orlistat—obesity	0.000125	0.00139	CcSEcCtD
Asenapine—Malnutrition—Bupropion—obesity	0.000125	0.00138	CcSEcCtD
Asenapine—HTR2A—pituitary gland—obesity	0.000124	0.00486	CbGeAlD
Asenapine—Convulsion—Sibutramine—obesity	0.000124	0.00137	CcSEcCtD
Asenapine—Hypertension—Sibutramine—obesity	0.000123	0.00137	CcSEcCtD
Asenapine—CYP1A2—endocrine gland—obesity	0.000123	0.00481	CbGeAlD
Asenapine—Dry mouth—Orlistat—obesity	0.000123	0.00136	CcSEcCtD
Asenapine—Dysgeusia—Bupropion—obesity	0.000122	0.00135	CcSEcCtD
Asenapine—Arthralgia—Sibutramine—obesity	0.000122	0.00135	CcSEcCtD
Asenapine—Anxiety—Sibutramine—obesity	0.000121	0.00134	CcSEcCtD
Asenapine—Anaphylactic shock—Orlistat—obesity	0.000121	0.00134	CcSEcCtD
Asenapine—Orthostatic hypotension—Topiramate—obesity	0.00012	0.00133	CcSEcCtD
Asenapine—Muscle spasms—Bupropion—obesity	0.00012	0.00133	CcSEcCtD
Asenapine—Breast disorder—Topiramate—obesity	0.000119	0.00132	CcSEcCtD
Asenapine—Dry mouth—Sibutramine—obesity	0.000119	0.00132	CcSEcCtD
Asenapine—Nervous system disorder—Orlistat—obesity	0.000118	0.00131	CcSEcCtD
Asenapine—Tremor—Bupropion—obesity	0.000117	0.00129	CcSEcCtD
Asenapine—Anaphylactic shock—Sibutramine—obesity	0.000117	0.00129	CcSEcCtD
Asenapine—HTR2A—digestive system—obesity	0.000116	0.00455	CbGeAlD
Asenapine—Alanine aminotransferase increased—Topiramate—obesity	0.000116	0.00129	CcSEcCtD
Asenapine—Anaemia—Bupropion—obesity	0.000115	0.00128	CcSEcCtD
Asenapine—HRH1—endocrine gland—obesity	0.000115	0.0045	CbGeAlD
Asenapine—Shock—Sibutramine—obesity	0.000115	0.00127	CcSEcCtD
Asenapine—Agitation—Bupropion—obesity	0.000115	0.00127	CcSEcCtD
Asenapine—Thrombocytopenia—Sibutramine—obesity	0.000114	0.00127	CcSEcCtD
Asenapine—Dysphagia—Topiramate—obesity	0.000114	0.00126	CcSEcCtD
Asenapine—Angioedema—Bupropion—obesity	0.000114	0.00126	CcSEcCtD
Asenapine—Tachycardia—Sibutramine—obesity	0.000114	0.00126	CcSEcCtD
Asenapine—ADRA2A—endocrine gland—obesity	0.000113	0.00442	CbGeAlD
Asenapine—Malaise—Bupropion—obesity	0.000112	0.00125	CcSEcCtD
Asenapine—Syncope—Bupropion—obesity	0.000112	0.00124	CcSEcCtD
Asenapine—Leukopenia—Bupropion—obesity	0.000112	0.00124	CcSEcCtD
Asenapine—HTR2A—adrenal gland—obesity	0.000111	0.00434	CbGeAlD
Asenapine—CYP1A2—liver—obesity	0.000111	0.00434	CbGeAlD
Asenapine—Musculoskeletal discomfort—Orlistat—obesity	0.00011	0.00122	CcSEcCtD
Asenapine—Loss of consciousness—Bupropion—obesity	0.00011	0.00121	CcSEcCtD
Asenapine—Abdominal discomfort—Topiramate—obesity	0.000109	0.00121	CcSEcCtD
Asenapine—Insomnia—Orlistat—obesity	0.000109	0.00121	CcSEcCtD
Asenapine—Hypotension—Sibutramine—obesity	0.000109	0.00121	CcSEcCtD
Asenapine—Convulsion—Bupropion—obesity	0.000108	0.0012	CcSEcCtD
Asenapine—CYP3A4—digestive system—obesity	0.000108	0.00421	CbGeAlD
Asenapine—Hypertension—Bupropion—obesity	0.000108	0.00119	CcSEcCtD
Asenapine—Loxapine—SLC6A4—obesity	0.000107	0.0482	CrCbGaD
Asenapine—Neutropenia—Topiramate—obesity	0.000107	0.00118	CcSEcCtD
Asenapine—Loxapine—DRD2—obesity	0.000106	0.0479	CrCbGaD
Asenapine—Musculoskeletal discomfort—Sibutramine—obesity	0.000106	0.00118	CcSEcCtD
Asenapine—Dyspepsia—Orlistat—obesity	0.000106	0.00118	CcSEcCtD
Asenapine—Arthralgia—Bupropion—obesity	0.000106	0.00118	CcSEcCtD
Asenapine—CYP2D6—digestive system—obesity	0.000106	0.00415	CbGeAlD
Asenapine—Anxiety—Bupropion—obesity	0.000106	0.00117	CcSEcCtD
Asenapine—Insomnia—Sibutramine—obesity	0.000106	0.00117	CcSEcCtD
Asenapine—Amoxapine—HTR2A—obesity	0.000105	0.0474	CrCbGaD
Asenapine—Gastrointestinal disorder—Orlistat—obesity	0.000104	0.00115	CcSEcCtD
Asenapine—Dyspnoea—Sibutramine—obesity	0.000104	0.00115	CcSEcCtD
Asenapine—Fatigue—Orlistat—obesity	0.000104	0.00115	CcSEcCtD
Asenapine—Dry mouth—Bupropion—obesity	0.000104	0.00115	CcSEcCtD
Asenapine—Somnolence—Sibutramine—obesity	0.000104	0.00115	CcSEcCtD
Asenapine—Weight increased—Topiramate—obesity	0.000104	0.00115	CcSEcCtD
Asenapine—Hyperglycaemia—Topiramate—obesity	0.000103	0.00114	CcSEcCtD
Asenapine—Dyspepsia—Sibutramine—obesity	0.000103	0.00114	CcSEcCtD
Asenapine—Anaphylactic shock—Bupropion—obesity	0.000102	0.00113	CcSEcCtD
Asenapine—Depression—Topiramate—obesity	0.000101	0.00112	CcSEcCtD
Asenapine—Gastrointestinal disorder—Sibutramine—obesity	0.000101	0.00112	CcSEcCtD
Asenapine—Shock—Bupropion—obesity	0.0001	0.00111	CcSEcCtD
Asenapine—Constipation—Sibutramine—obesity	9.98e-05	0.00111	CcSEcCtD
Asenapine—Nervous system disorder—Bupropion—obesity	9.98e-05	0.00111	CcSEcCtD
Asenapine—Thrombocytopenia—Bupropion—obesity	9.96e-05	0.0011	CcSEcCtD
Asenapine—Tachycardia—Bupropion—obesity	9.93e-05	0.0011	CcSEcCtD
Asenapine—Stomatitis—Topiramate—obesity	9.91e-05	0.0011	CcSEcCtD
Asenapine—HTR2A—endocrine gland—obesity	9.62e-05	0.00376	CbGeAlD
Asenapine—Hypotension—Bupropion—obesity	9.51e-05	0.00105	CcSEcCtD
Asenapine—Agranulocytosis—Topiramate—obesity	9.48e-05	0.00105	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Bupropion—obesity	9.27e-05	0.00103	CcSEcCtD
Asenapine—Insomnia—Bupropion—obesity	9.2e-05	0.00102	CcSEcCtD
Asenapine—Dyspnoea—Bupropion—obesity	9.07e-05	0.00101	CcSEcCtD
Asenapine—Somnolence—Bupropion—obesity	9.04e-05	0.001	CcSEcCtD
Asenapine—Oedema peripheral—Topiramate—obesity	8.99e-05	0.000996	CcSEcCtD
Asenapine—Connective tissue disorder—Topiramate—obesity	8.96e-05	0.000994	CcSEcCtD
Asenapine—Dyspepsia—Bupropion—obesity	8.96e-05	0.000993	CcSEcCtD
Asenapine—CYP3A4—endocrine gland—obesity	8.91e-05	0.00348	CbGeAlD
Asenapine—Hypersensitivity—Orlistat—obesity	8.88e-05	0.000985	CcSEcCtD
Asenapine—Gastrointestinal disorder—Bupropion—obesity	8.78e-05	0.000973	CcSEcCtD
Asenapine—Fatigue—Bupropion—obesity	8.77e-05	0.000972	CcSEcCtD
Asenapine—CYP2D6—endocrine gland—obesity	8.76e-05	0.00343	CbGeAlD
Asenapine—Constipation—Bupropion—obesity	8.7e-05	0.000964	CcSEcCtD
Asenapine—HTR2A—liver—obesity	8.67e-05	0.00339	CbGeAlD
Asenapine—Asthenia—Orlistat—obesity	8.65e-05	0.000959	CcSEcCtD
Asenapine—Hypersensitivity—Sibutramine—obesity	8.6e-05	0.000953	CcSEcCtD
Asenapine—Eye disorder—Topiramate—obesity	8.53e-05	0.000945	CcSEcCtD
Asenapine—Cardiac disorder—Topiramate—obesity	8.47e-05	0.000938	CcSEcCtD
Asenapine—Asthenia—Sibutramine—obesity	8.37e-05	0.000928	CcSEcCtD
Asenapine—Angiopathy—Topiramate—obesity	8.28e-05	0.000917	CcSEcCtD
Asenapine—Immune system disorder—Topiramate—obesity	8.24e-05	0.000913	CcSEcCtD
Asenapine—Loxapine—HTR2A—obesity	8.22e-05	0.037	CrCbGaD
Asenapine—Mediastinal disorder—Topiramate—obesity	8.22e-05	0.000911	CcSEcCtD
Asenapine—CYP3A4—liver—obesity	8.03e-05	0.00314	CbGeAlD
Asenapine—Mental disorder—Topiramate—obesity	7.99e-05	0.000886	CcSEcCtD
Asenapine—Dizziness—Orlistat—obesity	7.97e-05	0.000884	CcSEcCtD
Asenapine—Malnutrition—Topiramate—obesity	7.94e-05	0.00088	CcSEcCtD
Asenapine—CYP2D6—liver—obesity	7.9e-05	0.00309	CbGeAlD
Asenapine—Dysgeusia—Topiramate—obesity	7.78e-05	0.000862	CcSEcCtD
Asenapine—Dizziness—Sibutramine—obesity	7.72e-05	0.000855	CcSEcCtD
Asenapine—Vomiting—Orlistat—obesity	7.67e-05	0.00085	CcSEcCtD
Asenapine—Muscle spasms—Topiramate—obesity	7.64e-05	0.000846	CcSEcCtD
Asenapine—Rash—Orlistat—obesity	7.6e-05	0.000843	CcSEcCtD
Asenapine—Dermatitis—Orlistat—obesity	7.6e-05	0.000842	CcSEcCtD
Asenapine—Headache—Orlistat—obesity	7.55e-05	0.000837	CcSEcCtD
Asenapine—Hypersensitivity—Bupropion—obesity	7.5e-05	0.000831	CcSEcCtD
Asenapine—Tremor—Topiramate—obesity	7.44e-05	0.000825	CcSEcCtD
Asenapine—Vomiting—Sibutramine—obesity	7.42e-05	0.000822	CcSEcCtD
Asenapine—Rash—Sibutramine—obesity	7.36e-05	0.000816	CcSEcCtD
Asenapine—Dermatitis—Sibutramine—obesity	7.35e-05	0.000815	CcSEcCtD
Asenapine—Anaemia—Topiramate—obesity	7.34e-05	0.000814	CcSEcCtD
Asenapine—Headache—Sibutramine—obesity	7.31e-05	0.00081	CcSEcCtD
Asenapine—Asthenia—Bupropion—obesity	7.3e-05	0.000809	CcSEcCtD
Asenapine—Agitation—Topiramate—obesity	7.3e-05	0.000809	CcSEcCtD
Asenapine—Nausea—Orlistat—obesity	7.16e-05	0.000794	CcSEcCtD
Asenapine—Malaise—Topiramate—obesity	7.16e-05	0.000794	CcSEcCtD
Asenapine—Syncope—Topiramate—obesity	7.12e-05	0.000789	CcSEcCtD
Asenapine—Leukopenia—Topiramate—obesity	7.11e-05	0.000788	CcSEcCtD
Asenapine—Loss of consciousness—Topiramate—obesity	6.98e-05	0.000774	CcSEcCtD
Asenapine—Nausea—Sibutramine—obesity	6.93e-05	0.000768	CcSEcCtD
Asenapine—Convulsion—Topiramate—obesity	6.88e-05	0.000763	CcSEcCtD
Asenapine—Hypertension—Topiramate—obesity	6.86e-05	0.00076	CcSEcCtD
Asenapine—Arthralgia—Topiramate—obesity	6.76e-05	0.000749	CcSEcCtD
Asenapine—Anxiety—Topiramate—obesity	6.74e-05	0.000747	CcSEcCtD
Asenapine—Dizziness—Bupropion—obesity	6.73e-05	0.000746	CcSEcCtD
Asenapine—Dry mouth—Topiramate—obesity	6.61e-05	0.000733	CcSEcCtD
Asenapine—Vomiting—Bupropion—obesity	6.47e-05	0.000717	CcSEcCtD
Asenapine—Rash—Bupropion—obesity	6.41e-05	0.000711	CcSEcCtD
Asenapine—Dermatitis—Bupropion—obesity	6.41e-05	0.00071	CcSEcCtD
Asenapine—Shock—Topiramate—obesity	6.38e-05	0.000707	CcSEcCtD
Asenapine—Headache—Bupropion—obesity	6.37e-05	0.000706	CcSEcCtD
Asenapine—Nervous system disorder—Topiramate—obesity	6.36e-05	0.000705	CcSEcCtD
Asenapine—Thrombocytopenia—Topiramate—obesity	6.35e-05	0.000703	CcSEcCtD
Asenapine—Tachycardia—Topiramate—obesity	6.33e-05	0.000701	CcSEcCtD
Asenapine—Hypotension—Topiramate—obesity	6.06e-05	0.000671	CcSEcCtD
Asenapine—Nausea—Bupropion—obesity	6.04e-05	0.00067	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Topiramate—obesity	5.91e-05	0.000655	CcSEcCtD
Asenapine—Insomnia—Topiramate—obesity	5.86e-05	0.00065	CcSEcCtD
Asenapine—Dyspnoea—Topiramate—obesity	5.78e-05	0.00064	CcSEcCtD
Asenapine—Somnolence—Topiramate—obesity	5.76e-05	0.000639	CcSEcCtD
Asenapine—Dyspepsia—Topiramate—obesity	5.71e-05	0.000632	CcSEcCtD
Asenapine—Gastrointestinal disorder—Topiramate—obesity	5.6e-05	0.00062	CcSEcCtD
Asenapine—Fatigue—Topiramate—obesity	5.59e-05	0.000619	CcSEcCtD
Asenapine—Constipation—Topiramate—obesity	5.54e-05	0.000614	CcSEcCtD
Asenapine—Hypersensitivity—Topiramate—obesity	4.78e-05	0.000529	CcSEcCtD
Asenapine—Asthenia—Topiramate—obesity	4.65e-05	0.000515	CcSEcCtD
Asenapine—Dizziness—Topiramate—obesity	4.29e-05	0.000475	CcSEcCtD
Asenapine—Vomiting—Topiramate—obesity	4.12e-05	0.000457	CcSEcCtD
Asenapine—Rash—Topiramate—obesity	4.09e-05	0.000453	CcSEcCtD
Asenapine—Dermatitis—Topiramate—obesity	4.08e-05	0.000453	CcSEcCtD
Asenapine—Headache—Topiramate—obesity	4.06e-05	0.00045	CcSEcCtD
Asenapine—Nausea—Topiramate—obesity	3.85e-05	0.000427	CcSEcCtD
Asenapine—DRD4—Signaling Pathways—TGFB1—obesity	6.11e-07	5.71e-06	CbGpPWpGaD
Asenapine—HTR2C—GPCR downstream signaling—AKT1—obesity	6.1e-07	5.7e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—NQO1—obesity	6.07e-07	5.67e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NOS3—obesity	6.05e-07	5.66e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—PIK3R1—obesity	6.05e-07	5.66e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL6—obesity	6.04e-07	5.64e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL6—obesity	6.01e-07	5.61e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MMP9—obesity	6e-07	5.61e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—PIK3CA—obesity	5.99e-07	5.59e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—AGT—obesity	5.97e-07	5.58e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—PIK3CD—obesity	5.96e-07	5.57e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MMP9—obesity	5.95e-07	5.56e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—STAT3—obesity	5.94e-07	5.55e-06	CbGpPWpGaD
Asenapine—ADRA2C—GPCR downstream signaling—AKT1—obesity	5.93e-07	5.54e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—LPL—obesity	5.91e-07	5.53e-06	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	5.9e-07	5.51e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—SERPINE1—obesity	5.89e-07	5.51e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—PIK3CA—obesity	5.89e-07	5.5e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—PIK3CA—obesity	5.88e-07	5.49e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MMP9—obesity	5.87e-07	5.49e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—STAT3—obesity	5.86e-07	5.47e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOE—obesity	5.85e-07	5.47e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MYC—obesity	5.85e-07	5.47e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL6—obesity	5.84e-07	5.46e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MAPK8—obesity	5.84e-07	5.46e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TGFB1—obesity	5.84e-07	5.45e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—AKT1—obesity	5.82e-07	5.44e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—SLC2A4—obesity	5.82e-07	5.43e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GCG—obesity	5.82e-07	5.43e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—PIK3CB—obesity	5.8e-07	5.42e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MTOR—obesity	5.8e-07	5.42e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CAV1—obesity	5.8e-07	5.42e-06	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—AKT1—obesity	5.8e-07	5.41e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MAPK8—obesity	5.79e-07	5.41e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOA1—obesity	5.78e-07	5.4e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GPX1—obesity	5.77e-07	5.39e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—AKT1—obesity	5.77e-07	5.39e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—PIK3CA—obesity	5.77e-07	5.39e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MMP9—obesity	5.74e-07	5.37e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYCS—obesity	5.74e-07	5.36e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TYK2—obesity	5.73e-07	5.35e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MMP9—obesity	5.71e-07	5.34e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MAPK8—obesity	5.71e-07	5.34e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—PIK3CB—obesity	5.71e-07	5.33e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MTOR—obesity	5.71e-07	5.33e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—AKT1—obesity	5.7e-07	5.32e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—PIK3CB—obesity	5.7e-07	5.32e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MTOR—obesity	5.7e-07	5.32e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—RHOA—obesity	5.68e-07	5.31e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GGT1—obesity	5.63e-07	5.26e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GOT1—obesity	5.63e-07	5.26e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—PIK3R1—obesity	5.63e-07	5.26e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NOS3—obesity	5.63e-07	5.26e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CD36—obesity	5.62e-07	5.25e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MTOR—obesity	5.59e-07	5.22e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—PIK3CB—obesity	5.59e-07	5.22e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MAPK8—obesity	5.58e-07	5.22e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—AKT1—obesity	5.57e-07	5.2e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MMP9—obesity	5.56e-07	5.19e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MAPK8—obesity	5.56e-07	5.19e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—NCOA1—obesity	5.55e-07	5.18e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—AKT1—obesity	5.54e-07	5.18e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MYC—obesity	5.52e-07	5.15e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TGFB1—obesity	5.5e-07	5.14e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—STK11—obesity	5.47e-07	5.11e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYP19A1—obesity	5.47e-07	5.11e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MYC—obesity	5.44e-07	5.09e-06	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—PIK3CA—obesity	5.44e-07	5.08e-06	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—PIK3CA—obesity	5.43e-07	5.08e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TGFB1—obesity	5.43e-07	5.07e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MAPK8—obesity	5.4e-07	5.05e-06	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—PIK3CA—obesity	5.4e-07	5.04e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—AKT1—obesity	5.39e-07	5.04e-06	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—AKT1—obesity	5.38e-07	5.03e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—PIK3CA—obesity	5.36e-07	5.01e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—STAT3—obesity	5.34e-07	4.99e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—MTHFR—obesity	5.32e-07	4.98e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL6—obesity	5.3e-07	4.95e-06	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—AKT1—obesity	5.3e-07	4.95e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—STAT3—obesity	5.29e-07	4.94e-06	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—AKT1—obesity	5.29e-07	4.94e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—PIK3CA—obesity	5.29e-07	4.94e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PIK3CG—obesity	5.28e-07	4.93e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PPARA—obesity	5.22e-07	4.88e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—STAT3—obesity	5.22e-07	4.88e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL6—obesity	5.22e-07	4.87e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL6—obesity	5.2e-07	4.86e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—PIK3CA—obesity	5.2e-07	4.86e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—PIK3CB—obesity	5.19e-07	4.85e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MTOR—obesity	5.19e-07	4.85e-06	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—AKT1—obesity	5.19e-07	4.85e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL6—obesity	5.11e-07	4.77e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—STAT3—obesity	5.11e-07	4.77e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PPARG—obesity	5.1e-07	4.76e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—COMT—obesity	5.08e-07	4.75e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—STAT3—obesity	5.08e-07	4.75e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—AGT—obesity	5.06e-07	4.73e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MMP9—obesity	5.04e-07	4.71e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—POMC—obesity	5.03e-07	4.7e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GNB3—obesity	5.01e-07	4.68e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARGC1A—obesity	5.01e-07	4.68e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—INS—obesity	5e-07	4.67e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—HMOX1—obesity	4.99e-07	4.66e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—PIK3CA—obesity	4.97e-07	4.64e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MMP9—obesity	4.96e-07	4.64e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MYC—obesity	4.96e-07	4.63e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOE—obesity	4.96e-07	4.63e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MMP9—obesity	4.95e-07	4.63e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TGFB1—obesity	4.95e-07	4.62e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—STAT3—obesity	4.94e-07	4.62e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MYC—obesity	4.91e-07	4.59e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CAV1—obesity	4.91e-07	4.59e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MAPK8—obesity	4.9e-07	4.58e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TGFB1—obesity	4.9e-07	4.58e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOA1—obesity	4.9e-07	4.58e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—AKT1—obesity	4.89e-07	4.57e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GNAS—obesity	4.88e-07	4.56e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MMP9—obesity	4.86e-07	4.54e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MYC—obesity	4.85e-07	4.53e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TGFB1—obesity	4.84e-07	4.52e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MAPK8—obesity	4.82e-07	4.51e-06	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—AKT1—obesity	4.82e-07	4.5e-06	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL6—obesity	4.82e-07	4.5e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MAPK8—obesity	4.81e-07	4.5e-06	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL6—obesity	4.81e-07	4.5e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—AKT1—obesity	4.81e-07	4.5e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—AKT1—obesity	4.8e-07	4.49e-06	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL6—obesity	4.78e-07	4.47e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOB—obesity	4.78e-07	4.47e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL6—obesity	4.74e-07	4.43e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MYC—obesity	4.74e-07	4.43e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TGFB1—obesity	4.73e-07	4.42e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MAPK8—obesity	4.72e-07	4.41e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MYC—obesity	4.72e-07	4.41e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—AKT1—obesity	4.71e-07	4.4e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TGFB1—obesity	4.71e-07	4.4e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.69e-07	4.38e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—PIK3CA—obesity	4.68e-07	4.38e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL6—obesity	4.68e-07	4.37e-06	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—PIK3CA—obesity	4.66e-07	4.35e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PIK3CD—obesity	4.64e-07	4.34e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—PIK3CA—obesity	4.62e-07	4.32e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL6—obesity	4.61e-07	4.3e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MYC—obesity	4.59e-07	4.29e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ALB—obesity	4.58e-07	4.28e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TGFB1—obesity	4.58e-07	4.28e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—LPL—obesity	4.56e-07	4.26e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MMP9—obesity	4.51e-07	4.22e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—STAT3—obesity	4.48e-07	4.19e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PIK3CG—obesity	4.47e-07	4.18e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GPX1—obesity	4.45e-07	4.16e-06	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—AKT1—obesity	4.44e-07	4.15e-06	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—AKT1—obesity	4.44e-07	4.15e-06	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—AKT1—obesity	4.41e-07	4.12e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—STAT3—obesity	4.41e-07	4.12e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—STAT3—obesity	4.4e-07	4.11e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL6—obesity	4.4e-07	4.11e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MAPK8—obesity	4.39e-07	4.1e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PIK3R1—obesity	4.38e-07	4.1e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—NOS3—obesity	4.38e-07	4.1e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—AKT1—obesity	4.38e-07	4.09e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CD36—obesity	4.34e-07	4.05e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—STAT3—obesity	4.32e-07	4.04e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—AKT1—obesity	4.32e-07	4.04e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PPARG—obesity	4.32e-07	4.03e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—POMC—obesity	4.26e-07	3.98e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—AKT1—obesity	4.25e-07	3.97e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—INS—obesity	4.23e-07	3.96e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—PIK3CA—obesity	4.21e-07	3.93e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—PIK3CA—obesity	4.17e-07	3.9e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MYC—obesity	4.17e-07	3.89e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TGFB1—obesity	4.16e-07	3.88e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL6—obesity	4.15e-07	3.87e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—PIK3CA—obesity	4.12e-07	3.85e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—MTHFR—obesity	4.11e-07	3.84e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MYC—obesity	4.1e-07	3.83e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL6—obesity	4.09e-07	3.82e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MYC—obesity	4.09e-07	3.82e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TGFB1—obesity	4.09e-07	3.82e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TGFB1—obesity	4.08e-07	3.81e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—AKT1—obesity	4.06e-07	3.79e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PIK3CB—obesity	4.05e-07	3.78e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARA—obesity	4.03e-07	3.77e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—PIK3CA—obesity	4.03e-07	3.76e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MYC—obesity	4.01e-07	3.75e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—STAT3—obesity	4.01e-07	3.75e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PTGS2—obesity	4.01e-07	3.75e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—PIK3CA—obesity	4.01e-07	3.74e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TGFB1—obesity	4e-07	3.74e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PIK3CD—obesity	3.93e-07	3.67e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AGT—obesity	3.9e-07	3.65e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—PIK3CA—obesity	3.9e-07	3.64e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ALB—obesity	3.88e-07	3.63e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—AKT1—obesity	3.83e-07	3.57e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOE—obesity	3.83e-07	3.57e-06	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—AKT1—obesity	3.81e-07	3.56e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CAV1—obesity	3.79e-07	3.54e-06	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PIK3CA—obesity	3.79e-07	3.54e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOA1—obesity	3.78e-07	3.53e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—AKT1—obesity	3.78e-07	3.53e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MYC—obesity	3.73e-07	3.48e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL6—obesity	3.73e-07	3.48e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TGFB1—obesity	3.72e-07	3.48e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—NOS3—obesity	3.71e-07	3.47e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PIK3R1—obesity	3.71e-07	3.47e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL6—obesity	3.69e-07	3.45e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL6—obesity	3.65e-07	3.41e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL6—obesity	3.57e-07	3.33e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL6—obesity	3.55e-07	3.31e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—PIK3CA—obesity	3.54e-07	3.3e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—PIK3CA—obesity	3.48e-07	3.25e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—PIK3CA—obesity	3.47e-07	3.24e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PIK3CG—obesity	3.45e-07	3.23e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL6—obesity	3.45e-07	3.22e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—AKT1—obesity	3.44e-07	3.21e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PIK3CB—obesity	3.43e-07	3.2e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—AKT1—obesity	3.41e-07	3.18e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—PIK3CA—obesity	3.41e-07	3.18e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PTGS2—obesity	3.4e-07	3.17e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—AKT1—obesity	3.36e-07	3.14e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARG—obesity	3.33e-07	3.11e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—AKT1—obesity	3.29e-07	3.07e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—POMC—obesity	3.29e-07	3.07e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—AKT1—obesity	3.27e-07	3.06e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—INS—obesity	3.27e-07	3.05e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—AKT1—obesity	3.18e-07	2.97e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—PIK3CA—obesity	3.17e-07	2.96e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL6—obesity	3.13e-07	2.93e-06	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—AKT1—obesity	3.09e-07	2.89e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6—obesity	3.08e-07	2.88e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6—obesity	3.07e-07	2.87e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PIK3CD—obesity	3.04e-07	2.84e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6—obesity	3.02e-07	2.82e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ALB—obesity	3e-07	2.8e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—AKT1—obesity	2.89e-07	2.7e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—NOS3—obesity	2.87e-07	2.68e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PIK3R1—obesity	2.87e-07	2.68e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—AKT1—obesity	2.84e-07	2.66e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—AKT1—obesity	2.84e-07	2.65e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6—obesity	2.8e-07	2.62e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—AKT1—obesity	2.78e-07	2.6e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PIK3CB—obesity	2.65e-07	2.47e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PTGS2—obesity	2.62e-07	2.45e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—AKT1—obesity	2.59e-07	2.42e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PIK3CA—obesity	2.47e-07	2.3e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PIK3CA—obesity	2.09e-07	1.95e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—AKT1—obesity	2.02e-07	1.88e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—AKT1—obesity	1.71e-07	1.6e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PIK3CA—obesity	1.61e-07	1.51e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AKT1—obesity	1.32e-07	1.23e-06	CbGpPWpGaD
